Short-term fluctuations in the detection of cervical human papillomavirus DNA

Cosette M. Wheeler, Catherine E. Greer, Thomas Becker, William C. Hunt, Steven M. Anderson, M. Michele Manos

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Objective: To obtain point and cumulative prevalence estimates of cervical human papillomavirus (HPV) infection using two HPV DNA detection methods with different end point sensitivities; compare cervical swab and cervicovaginal lavage specimen collection methods for subsequent evaluation by polymerase chain reaction (PCR); and evaluate potential effects of the menstrual cycle on HPV DNA detection. Methods: Seventy-two college women participated in a 10-week follow-up study. Cervical samples were obtained for HPV DNA detection and typing at each clinic visit, and information was collected concerning menstrual cycle and sexual and hygienic behaviors. Human papillomavirus DNA was detected by the ViraPap HPV DNA dot-blot assay and a broad-spectrum PCR HPV DNA amplification system. Results: On a weekly basis, point prevalence for HPV infection by the ViraPap assay ranged from 4.2 to 9.7%, and the cumulative prevalence was 13.9%. Point prevalence by the broad- spectrum PCR assay ranged from 20.8 to 47.2%, and the cumulative HPV prevalence was 58.3%. Using cervicovaginal lavage specimens, we found lower cervical HPV prevalence estimates when compared with cervical swab specimens in the HPV PCR-based assay. No correlation between HPV DNA detection and phase of menstrual cycle was observed. Conclusion: Short-term HPV DNA detection is highly variable within individuals; therefore, single-point measurements of cervical HPV have limitations when assessing an individual's HPV status. The relationship between short-term and long-term HPV DNA persistence profiles may prove relevant to determining the risk of developing cervical intraepithelial neoplasia.

Original languageEnglish (US)
Pages (from-to)261-268
Number of pages8
JournalObstetrics and Gynecology
Volume88
Issue number2
DOIs
StatePublished - Aug 1996
Externally publishedYes

Fingerprint

DNA
Menstrual Cycle
Polymerase Chain Reaction
Papillomavirus Infections
Therapeutic Irrigation
Specimen Handling
Cervical Intraepithelial Neoplasia
DNA Fingerprinting
Ambulatory Care
Sexual Behavior

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Short-term fluctuations in the detection of cervical human papillomavirus DNA. / Wheeler, Cosette M.; Greer, Catherine E.; Becker, Thomas; Hunt, William C.; Anderson, Steven M.; Manos, M. Michele.

In: Obstetrics and Gynecology, Vol. 88, No. 2, 08.1996, p. 261-268.

Research output: Contribution to journalArticle

Wheeler, Cosette M. ; Greer, Catherine E. ; Becker, Thomas ; Hunt, William C. ; Anderson, Steven M. ; Manos, M. Michele. / Short-term fluctuations in the detection of cervical human papillomavirus DNA. In: Obstetrics and Gynecology. 1996 ; Vol. 88, No. 2. pp. 261-268.
@article{f0acbfeeaa014aae8a7bb0d941a9ff49,
title = "Short-term fluctuations in the detection of cervical human papillomavirus DNA",
abstract = "Objective: To obtain point and cumulative prevalence estimates of cervical human papillomavirus (HPV) infection using two HPV DNA detection methods with different end point sensitivities; compare cervical swab and cervicovaginal lavage specimen collection methods for subsequent evaluation by polymerase chain reaction (PCR); and evaluate potential effects of the menstrual cycle on HPV DNA detection. Methods: Seventy-two college women participated in a 10-week follow-up study. Cervical samples were obtained for HPV DNA detection and typing at each clinic visit, and information was collected concerning menstrual cycle and sexual and hygienic behaviors. Human papillomavirus DNA was detected by the ViraPap HPV DNA dot-blot assay and a broad-spectrum PCR HPV DNA amplification system. Results: On a weekly basis, point prevalence for HPV infection by the ViraPap assay ranged from 4.2 to 9.7{\%}, and the cumulative prevalence was 13.9{\%}. Point prevalence by the broad- spectrum PCR assay ranged from 20.8 to 47.2{\%}, and the cumulative HPV prevalence was 58.3{\%}. Using cervicovaginal lavage specimens, we found lower cervical HPV prevalence estimates when compared with cervical swab specimens in the HPV PCR-based assay. No correlation between HPV DNA detection and phase of menstrual cycle was observed. Conclusion: Short-term HPV DNA detection is highly variable within individuals; therefore, single-point measurements of cervical HPV have limitations when assessing an individual's HPV status. The relationship between short-term and long-term HPV DNA persistence profiles may prove relevant to determining the risk of developing cervical intraepithelial neoplasia.",
author = "Wheeler, {Cosette M.} and Greer, {Catherine E.} and Thomas Becker and Hunt, {William C.} and Anderson, {Steven M.} and Manos, {M. Michele}",
year = "1996",
month = "8",
doi = "10.1016/0029-7844(96)00120-2",
language = "English (US)",
volume = "88",
pages = "261--268",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Short-term fluctuations in the detection of cervical human papillomavirus DNA

AU - Wheeler, Cosette M.

AU - Greer, Catherine E.

AU - Becker, Thomas

AU - Hunt, William C.

AU - Anderson, Steven M.

AU - Manos, M. Michele

PY - 1996/8

Y1 - 1996/8

N2 - Objective: To obtain point and cumulative prevalence estimates of cervical human papillomavirus (HPV) infection using two HPV DNA detection methods with different end point sensitivities; compare cervical swab and cervicovaginal lavage specimen collection methods for subsequent evaluation by polymerase chain reaction (PCR); and evaluate potential effects of the menstrual cycle on HPV DNA detection. Methods: Seventy-two college women participated in a 10-week follow-up study. Cervical samples were obtained for HPV DNA detection and typing at each clinic visit, and information was collected concerning menstrual cycle and sexual and hygienic behaviors. Human papillomavirus DNA was detected by the ViraPap HPV DNA dot-blot assay and a broad-spectrum PCR HPV DNA amplification system. Results: On a weekly basis, point prevalence for HPV infection by the ViraPap assay ranged from 4.2 to 9.7%, and the cumulative prevalence was 13.9%. Point prevalence by the broad- spectrum PCR assay ranged from 20.8 to 47.2%, and the cumulative HPV prevalence was 58.3%. Using cervicovaginal lavage specimens, we found lower cervical HPV prevalence estimates when compared with cervical swab specimens in the HPV PCR-based assay. No correlation between HPV DNA detection and phase of menstrual cycle was observed. Conclusion: Short-term HPV DNA detection is highly variable within individuals; therefore, single-point measurements of cervical HPV have limitations when assessing an individual's HPV status. The relationship between short-term and long-term HPV DNA persistence profiles may prove relevant to determining the risk of developing cervical intraepithelial neoplasia.

AB - Objective: To obtain point and cumulative prevalence estimates of cervical human papillomavirus (HPV) infection using two HPV DNA detection methods with different end point sensitivities; compare cervical swab and cervicovaginal lavage specimen collection methods for subsequent evaluation by polymerase chain reaction (PCR); and evaluate potential effects of the menstrual cycle on HPV DNA detection. Methods: Seventy-two college women participated in a 10-week follow-up study. Cervical samples were obtained for HPV DNA detection and typing at each clinic visit, and information was collected concerning menstrual cycle and sexual and hygienic behaviors. Human papillomavirus DNA was detected by the ViraPap HPV DNA dot-blot assay and a broad-spectrum PCR HPV DNA amplification system. Results: On a weekly basis, point prevalence for HPV infection by the ViraPap assay ranged from 4.2 to 9.7%, and the cumulative prevalence was 13.9%. Point prevalence by the broad- spectrum PCR assay ranged from 20.8 to 47.2%, and the cumulative HPV prevalence was 58.3%. Using cervicovaginal lavage specimens, we found lower cervical HPV prevalence estimates when compared with cervical swab specimens in the HPV PCR-based assay. No correlation between HPV DNA detection and phase of menstrual cycle was observed. Conclusion: Short-term HPV DNA detection is highly variable within individuals; therefore, single-point measurements of cervical HPV have limitations when assessing an individual's HPV status. The relationship between short-term and long-term HPV DNA persistence profiles may prove relevant to determining the risk of developing cervical intraepithelial neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=0030221848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030221848&partnerID=8YFLogxK

U2 - 10.1016/0029-7844(96)00120-2

DO - 10.1016/0029-7844(96)00120-2

M3 - Article

VL - 88

SP - 261

EP - 268

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2

ER -